Showing results (1-10 of 26) with videos related to
Sort By:
Pageof 3
Farmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|August 31, 2024
[Translated article] The role of artificial intelligence in scientific publishing: perspectives from hospital pharmacyVicente Gimeno-Ballester, Cristina Trigo-VicenteFarmacia Hospitalaria : Organo Oficial De Expresion Cientifica De La Sociedad Espanola De Farmacia Hospitalaria|June 26, 2024
The role of artificial intelligence in scientific publishing: Perspectives from Hospital PharmacyVicente Gimeno-Ballester, Cristina Trigo-VicenteExpert Review of Pharmacoeconomics & Outcomes Research|April 25, 2014
Cost-effectiveness of protease inhibitor based regimens for chronic hepatitis C: a systematic review of published literatureRamón San Miguel, Vicente Gimeno-Ballester, Javier MarExpert Review of Pharmacoeconomics & Outcomes Research|September 2, 2015
Cost-effectiveness analysis of simeprevir with daclatasvir for non-cirrhotic genotype-1b-naïve patients plus chronic hepatitis CVicente Gimeno-Ballester, Javier Mar, Ramón San MiguelClinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico|March 6, 2026
Pharmacokinetic insights into atezolizumab SC: viability of extended dosing intervals beyond the standard regimenVicente Gimeno-Ballester, Elena Herranz-Bayo, Cristina Trigo-VicenteGut|October 15, 2014
Cost-effectiveness analysis of sofosbuvir-based regimens for chronic hepatitis CRamón San Miguel, Vicente Gimeno-Ballester, Antonio Blázquez, et al.European Journal of Hospital Pharmacy : Science and Practice|October 24, 2020
Cost-effectiveness analysis of infliximab, adalimumab, golimumab, vedolizumab and tofacitinib for moderate to severe ulcerative colitis in SpainCristina Trigo-Vicente, Vicente Gimeno-Ballester, Alejandro López-Del ValCost Effectiveness and Resource Allocation : C/E|July 31, 2023
INES: Interactive tool for construction and extrapolation of partitioned survival modelsVicente Gimeno-Ballester, Daniel Perez-Troncoso, Antonio Olry-Labry, et al.Medicina Clinica|December 15, 2015
[Cost-effectiveness analysis of sofosbuvir-simeprevir regimens for chronic hepatitis C genotype 1 patients with advanced fibrosis]Javier Mar, Lorea Mar-Barrutia, Vicente Gimeno-Ballester, et al.Expert Review of Gastroenterology & Hepatology|August 9, 2016
Cost-effectiveness analysis of therapeutic options for chronic hepatitis C genotype 3 infected patientsVicente Gimeno-Ballester, Javier Mar, Aisling O'Leary, et al.Pageof 3